Carlson Financial’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$482K Sell
7,448
-3
-0% -$164 0.25% 89
2026
Q1
$390K Hold
7,451
0.23% 104
2025
Q4
$382K Buy
+7,451
New +$345K 0.22% 104

Other funds holding SBIO

Carlson Financial's SBIO Position: Q2 2026 in Review

Carlson Financial reduced its ALPS Medical Breakthroughs ETF (SBIO) stake by 0.04% in Q2 2026, selling an estimated $164 and leaving 7,448 shares worth $482K. The position accounts for 0.25% of the portfolio, ranked #89.

Carlson Financial first reported a position in SBIO in Q4 2025 and has held it in 3 quarters since. 65 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.

  • Carlson Financial held 7,448 shares of ALPS Medical Breakthroughs ETF worth $482K as of Q2 2026.
  • Carlson Financial sold 3 ALPS Medical Breakthroughs ETF shares in Q2 2026, an estimated $164.
  • ALPS Medical Breakthroughs ETF made up 0.25% of Carlson Financial's portfolio in Q2 2026, its #89 holding.
  • Carlson Financial first reported a position in ALPS Medical Breakthroughs ETF in Q4 2025 and has held it in 3 quarters since.
  • 65 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.

Based on Carlson Financial's 13F filing for Q2 2026, filed 24 Aug 2026.